Neurosteroids in Glioma: A Novel Therapeutic Concept.

glioblastoma glioma neuro-oncology neurosteroids surgical intervention therapeutic targets

Journal

Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444

Informations de publication

Date de publication:
02 Aug 2024
Historique:
received: 01 07 2024
revised: 30 07 2024
accepted: 31 07 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 29 8 2024
Statut: epublish

Résumé

Glioma, a diverse group of brain and spinal cord tumors arising from glial cells, is characterized by varying degrees of malignancy, with some types exhibiting highly aggressive behavior, rapid proliferation, and invasive growth patterns, posing significant therapeutic challenges. This review delves into the complex interactions between glioma cells, neurotransmitters, and neurosteroids, emphasizing their potential as therapeutic targets. Key neurotransmitters, like glutamate and gamma-aminobutyric acid (GABA), play crucial roles in glioma growth, invasion, and treatment response. This review examines the involvement of neurosteroids in glioma biology and explores innovative therapeutic strategies targeting these systems. It encompasses the biosynthesis and mechanisms of neurosteroids, interactions between gliomas and neurotransmitters, the spatial distribution of neurosteroid synthesis in gliomas, the role of ion channels, hormonal influences, enzyme modulation, and the neuroimmune system in glioma progression. Additionally, it highlights the potential of neurosteroids to modulate these pathways for therapeutic benefit.

Identifiants

pubmed: 39202716
pii: life14080975
doi: 10.3390/life14080975
pmc: PMC11355226
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Int J Mol Sci. 2022 Dec 29;24(1):
pubmed: 36614002
J Neurosci. 1999 Jul 15;19(14):5942-54
pubmed: 10407033
J Hematol Oncol. 2021 Oct 29;14(1):176
pubmed: 34715891
Nat Rev Neurosci. 2019 May;20(5):282-297
pubmed: 30792501
J Neurophysiol. 2001 Feb;85(2):790-803
pubmed: 11160513
Nat Rev Endocrinol. 2013 Apr;9(4):241-50
pubmed: 23438839
Curr Treat Options Oncol. 2020 Jul 30;21(9):77
pubmed: 32734428
Neuropsychopharmacology. 2024 Jan;49(1):73-82
pubmed: 37369775
Nat Med. 2001 Sep;7(9):1010-5
pubmed: 11533703
Cells. 2022 Jun 18;11(12):
pubmed: 35741094
Neuro Oncol. 2007 Jul;9(3):319-25
pubmed: 17522333
Int Immunopharmacol. 2018 Nov;64:33-41
pubmed: 30145468
BMC Cancer. 2024 Jan 15;24(1):82
pubmed: 38225589
Pharmacol Ther. 2007 Oct;116(1):7-19
pubmed: 17560657
Glia. 2019 Jun;67(6):1179-1195
pubmed: 30720218
Nat Med. 2011 Sep 11;17(10):1269-74
pubmed: 21909104
Brain Sci. 2018 Apr 21;8(4):
pubmed: 29690521
Front Immunol. 2022 Jul 29;13:940095
pubmed: 35967446
Neuron. 1993 Sep;11(3):523-30
pubmed: 8398145
Expert Opin Investig Drugs. 2012 May;21(5):575-8
pubmed: 22404218
Front Immunol. 2014 Sep 25;5:461
pubmed: 25309543
J Neurosci Res. 1999 Dec 15;58(6):815-22
pubmed: 10583912
Epilepsy Res. 2003 Apr;54(1):11-9
pubmed: 12742591
J Neural Transm Gen Sect. 1994;96(3):233-41
pubmed: 7826574
Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14602-7
pubmed: 16984997
Behav Neurol. 2015;2015:862634
pubmed: 26346755
J Steroid Biochem Mol Biol. 1990 Nov 20;37(3):395-403
pubmed: 2257243
Front Vet Sci. 2017 Apr 13;4:53
pubmed: 28451590
Brain Res Mol Brain Res. 1995 Jun;30(2):287-300
pubmed: 7637579
Proc Natl Acad Sci U S A. 2001 May 22;98(11):6372-7
pubmed: 11331750
Crit Rev Neurobiol. 2003;15(3-4):197-234
pubmed: 15248811
Oncotarget. 2018 Dec 25;9(101):37564-37580
pubmed: 30680070
Int Immunopharmacol. 2021 Feb;91:107265
pubmed: 33360829
Sci Rep. 2019 Feb 4;9(1):1220
pubmed: 30718548
Front Mol Neurosci. 2019 Mar 29;12:65
pubmed: 30983966
Prog Brain Res. 2010;186:113-37
pubmed: 21094889
Biomed Pharmacother. 2023 May;161:114410
pubmed: 36812710
J Neurosci. 2020 Jul 29;40(31):5922-5936
pubmed: 32611707
Glia. 2002 Jun;38(4):281-91
pubmed: 12007141
Oncoimmunology. 2012 May 1;1(3):298-305
pubmed: 22737605
Mol Ther Oncolytics. 2020 Dec 25;20:166-174
pubmed: 33575479
Cell Calcium. 2013 Mar;53(3):187-94
pubmed: 23261316
Cells. 2020 Aug 21;9(9):
pubmed: 32825553
Cell Stem Cell. 2017 Apr 6;20(4):422-424
pubmed: 28388423
Cancer Res. 1999 Sep 1;59(17):4383-91
pubmed: 10485487
J Neurosci. 2005 May 11;25(19):4706-18
pubmed: 15888646
Brain Sci. 2024 Mar 14;14(3):
pubmed: 38539663
Life Sci. 2020 May 15;249:117536
pubmed: 32165211
Neuro Oncol. 2021 Aug 2;23(8):1231-1251
pubmed: 34185076
Life (Basel). 2024 Apr 30;14(5):
pubmed: 38792602
Nature. 2017 Sep 28;549(7673):533-537
pubmed: 28959975
Neurobiol Dis. 2020 Jul;141:104942
pubmed: 32423877
Glia. 2011 Aug;59(8):1181-9
pubmed: 21192095
Eur J Endocrinol. 2001 Dec;145(6):669-79
pubmed: 11720889
Cell. 2015 May 7;161(4):803-16
pubmed: 25913192
Mol Neurobiol. 2004 Feb;29(1):61-71
pubmed: 15034223
PLoS One. 2012;7(5):e37041
pubmed: 22615883
Endocrinol Diabetes Metab. 2021 Oct;4(4):e00289
pubmed: 34505421
Philos Trans R Soc Lond B Biol Sci. 2014 Feb 03;369(1638):20130095
pubmed: 24493743
Am J Physiol Cell Physiol. 2011 Sep;301(3):C541-9
pubmed: 21543740
Neuropharmacology. 2004 May;46(6):856-64
pubmed: 15033345

Auteurs

Ava Hogan (A)

Department of Neuroscience, University of Virginia, Charlottesville, VA 22903, USA.

Melike Mut (M)

Department of Neurosurgery, University of Virginia, Charlottesville, VA 22903, USA.

Classifications MeSH